Pharmaceutical

ESC 2024: Insights into RNA as therapeutic target and tool

A panel of researchers gave presentations on the clinical evidence for the role of RNA in therapy for cardiovascular conditions.

Sep 6, 2024 - 04:00
ESC 2024: Insights into RNA as therapeutic target and tool
A panel of researchers gave presentations on the clinical evidence for the role of RNA in therapy for cardiovascular conditions.
Read the original article

Tags:

Previous Article

6 Signs Of Collagen Deficiency

Next Article

ESC 2024: New PACMAN-AMI trial analysis sheds insights on Praluent efficacy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Plus Therapeutics and PPS expand partnership for cGMP drug production

Plus Therapeutics and PPS expand partnership for cGMP d...

May 2, 2023

Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases

Syros Pharmaceuticals gets grant for CDK7 inhibitors fo...

Jun 12, 2024

China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor

China NMPA grants IND clearance for Fermion’s TYK2 JH2 ...

Feb 6, 2024